SCHEMBL17681380

SCHEMBL17681380

Cc1cc(NS(=O)(=O)c2ccc(NC(=O)c3cc(-c4ccccc4)nc4ccccc34)cc2)no1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 12/20 0.79
▸ KMT2A Q03164 12/20 0.79
▸ POLB P06746 6/20 0.79
▸ CNR1 P21554 5/20 0.78
▸ NPSR1 Q6W5P4 3/20 0.78
▸ KDM4E B2RXH2 7/20 0.73
▸ ALDH1A1 P00352 6/20 0.73
▸ HTT P42858 4/20 0.73
▸ GPR55 Q9Y2T6 4/20 0.73
▸ LMNA P02545 3/20 0.73
▸ MAPT P10636 6/20 0.71
▸ HPGD P15428 4/20 0.71
▸ CYP2C9 P11712 3/20 0.67
▸ CYP1A2 P05177 2/20 0.67
▸ TDP1 Q9NUW8 2/20 0.67
▸ CYP2C19 P33261 2/20 0.67
▸ SMN1; SMN2 Q16637 2/20 0.67
▸ CYP2D6 P10635 1/20 0.67
▸ GAA P10253 1/20 0.67
▸ L3MBTL1 Q9Y468 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17681390 0.83 MEN1 (1.00) MEN1KMT2APOLBCNR1NPSR1
SCHEMBL17681381 0.83 MAPT (0.79) MEN1KMT2APOLBCNR1NPSR1
SCHEMBL17689185 0.83 MEN1 (0.76) MEN1KMT2APOLBCNR1NPSR1
SCHEMBL17681377 0.81 MEN1 (0.76) MEN1KMT2APOLBCNR1NPSR1
SCHEMBL17681384 0.80 MEN1 (1.00) MEN1KMT2APOLBCNR1NPSR1
SCHEMBL16783170 0.79 KDM4E (0.77) MEN1KMT2APOLBCNR1NPSR1
SCHEMBL13253431 0.79 MEN1 (0.72) MEN1KMT2APOLBCNR1NPSR1
SCHEMBL27697516 0.78 ALDH1A1 (0.73) MEN1KMT2APOLBCNR1KDM4E
SCHEMBL17681383 0.78 MEN1 (1.00) MEN1KMT2APOLBCNR1KDM4E
SCHEMBL14970875 0.77 CYP3A4 (1.00) MEN1KMT2AKDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9315464-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2016-04-19 — — US claimed
US-10350225-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2019-07-16 — — US disclosed
US-10350225-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2019-07-16 — — US disclosed
US-10076529-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2018-09-18 — — US disclosed
US-9315464-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2016-04-19 — — US disclosed
US-9315464-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2016-04-19 — — US disclosed
US-9315464-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2016-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10076529-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase RNGTT, MED23, MED25 MEN1 4837/4885KMT2A 534/4885POLB 117/4885
US-10350225-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase RNGTT, MED23, MED25 MEN1 4837/4885KMT2A 534/4885POLB 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback